Immunome, Inc. (IMNM)
NASDAQ·Healthcare·Biotechnology
$23.68
+0.81%
Mkt Cap $2.10B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $876.03K | — | — | -$0.59 | -$0.75 | -27.08% | — | — |
| Q4 2025 Nov 6, 2025 | $850.00K | — | — | -$0.57 | -$0.65 | -14.04% | — | — |
| Q3 2025 Aug 6, 2025 | $833.33K | $4.01M | +381.80% | -$0.52 | -$0.50 | +3.85% | — | — |
| Q2 2025 May 12, 2025 | $457.14K | $2.93M | +540.07% | -$0.66 | -$0.52 | +21.21% | — | — |
| Q1 2025 Mar 19, 2025 | $3.15M | $2.74M | -12.99% | -$0.68 | -$0.84 | -23.53% | — | — |
| Q4 2024 Nov 13, 2024 | $3.16M | $2.91M | -7.79% | -$0.60 | -$0.78 | -30.00% | — | — |
| Q3 2024 Aug 12, 2024 | $2.55M | $2.36M | -7.29% | -$0.38 | -$0.49 | -28.95% | — | — |
| Q2 2024 May 14, 2024 | $2.80M | $1.03M | -63.25% | -$0.80 | -$0.34 | +57.50% | — | — |
| Q1 2024 Mar 28, 2024 | $2.07M | $3.83M | +85.13% | -$0.28 | -$0.54 | -92.86% | — | — |
| Q4 2023 Nov 9, 2023 | $3.56M | $3.56M | +0.00% | -$0.17 | -$0.36 | -111.76% | — | — |
| Q3 2023 Aug 9, 2023 | — | $4.26M | — | -$0.16 | -$0.46 | -187.50% | — | — |
| Q2 2023 May 5, 2023 | — | $2.36M | — | $0.59 | -$0.35 | -159.32% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | $0.67 | -$0.64 | -195.52% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.76 | -$0.75 | +1.32% | — | — |
| Q3 2022 Aug 5, 2022 | — | — | — | -$0.75 | -$0.74 | +1.33% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.69 | -$0.96 | -39.13% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$0.81 | -$0.66 | +18.52% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.50 | -$0.65 | -30.00% | — | — |
| Q3 2021 Aug 16, 2021 | $4.70M | — | — | -$0.39 | -$0.46 | -17.95% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$0.41 | -$0.37 | +9.76% | — | — |